More articles from Oncology: Basic, Translational & Therapy

You have access
Role of F-18 FDG PET/CT in response assessment of Ewing's sarcoma family of tumors
Amrita Tiwary, Mahesh Chauhan, Mattakarottu Jacob, Aniruddha Pandit, Amit Sharma, Rajeev Kumar and Mudalsha Ravina

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 386;
You have access
Integrin receptor imaging with 68Ga-NOTA-PRGD2 PET/CT: A pilot study of a healthy volunteer and 3 patients
Kun Zheng, Zhaohui Zhu, Haiqun Xing, Yaping Luo, Jiyun Shi, Xiaoyuan Chen and Fang Li

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 277;
You have access
18F-FDG and FLT PET for early prediction of response to targeted chemotherapy in advanced lung cancer
Lauren Zollinger, Kathryn Morton, Wallace Akerley, Dan Kadrmas, Paul Christian, Regan Butterfield and John Hoffman

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 384;
You have access
Response assessment of gastric cancer to neoadjuvant chemotherapy using a modified 18F-FDG PET/CT protocol
Chenxi Wu, Xiaoyi Li, Ximin Shi, Yonghong Dang, Nan Hu, Zhaohui Zhu and Fang Li

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 388;
You have access
¹⁸F-FDG PET can evaluate immediate cytotoxic effects induced by the photoimmunotherapy before changes in tumor size
Kohei Sano, Makoto Mitsunaga, Takahito Nakajima, Peter Choyke and Hisataka Kobayashi

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 385;
You have access
Quantitative analysis of [¹⁸F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry
Kuangyu Shi, Constantin Maftei, Christine Bayer, Sabrina Astner, Florian Gaertner, Peter Vaupel, Markus Schwaiger, Sung-Cheng Huang and Sibylle Ziegler

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 216;
You have access
Individualized absorbed doses to kidney and bone marrow in 200 patients undergoing therapy with 177Lu-octreotate
Mattias Sandstrom, Ulrike Garske, Dan Granberg, Charles Widström, Barbro Eriksson, Anders Sundin, Hans Lundqvist and Mark Lubberink

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 225;
You have access
Annotating MYC oncogene status with 89Zr-transferrin imaging
Michael Evans, Jason Holland, Jason Lewis and Charles Sawyers

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 111;
You have access
Evaluation of ⁶⁴Cu-ATSM for an internal radiotherapy agent against CD133⁺ cancer stem cells with human colon carcinoma: ⁶⁴Cu-ATSM treatment caused cell apoptosis
Yukie Yoshii, Takako Furukawa, Yasushi Kiyono, Hiroshi Yoshii, Mitsuyoshi Yoshimoto, Yasuhisa Fujibayashi and Tsuneo Saga

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 176;
You have access
[¹³¹I]MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa)
Shawn Hillier, Kimberley Rubino, Kevin Maresca, John Marquis, Mathias Tesson, Craig Zimmerman, William Eckelman, Rob Mairs, John Joyal and John Babich

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 170;

Main menu

User menu

Search

More articles from Oncology: Basic, Translational & Therapy

Pages